Univercells
Biotechnology company using advanced manufacturing technologies to make "Biologics for all" by developing innovative, cost-effective production platforms for vaccines, cell therapies, and other biologics.
Website
https://www.univercells.comLocation
Gosselies, Belgium
Founded
2013
Investors
1
Categories
biotech, biomanufacturing, vaccines, cell-therapy
Notes
Univercells is a biotechnology company focused on making biologics accessible to everyone through innovative manufacturing technologies. The company is headquartered in Gosselies, Belgium.
The company's mission is "Biologics for all" - developing production platforms that dramatically reduce the cost and complexity of manufacturing biological medicines. Univercells' technologies enable:
- Decentralized biomanufacturing
- Reduced capital and operating costs
- Scalable production from clinical to commercial scale
- Applications in vaccines, cell therapies, and other biologics
The company has spun out several businesses focused on specific applications of its manufacturing platform.
Team
- Hugues Bultot - Founder & Chief Executive Officer
- LinkedIn: linkedin.com/in/huguesbultot
Additional Research Findings
- Advanced biomanufacturing platform
- "Biologics for all" mission
- Vaccine and cell therapy production
- Decentralized manufacturing approach
- Gosselies, Belgium headquarters
- Founded in 2013
- Multiple spinout companies
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Adjuvant Capital | Washington, DC, USA | biotech-focused | seedseries-a+3 | 16 |